Showing results (2731-2740 of 3,166) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|December 7, 2013
The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cellsJenna Kahn, Thomas J Hayman, Muhammad Jamal, et al.Neuro-Oncology|December 7, 2013
Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotypeShaun D Fouse, Jean L Nakamura, C David James, et al.Neuro-Oncology|December 7, 2013
Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysisJiaxin Zhao, Wenjie Ma, Hong ZhaoNeuro-Oncology|December 12, 2013
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cellsFabian Wolpert, Isabel Tritschler, Alexander Steinle, et al.Neuro-Oncology|December 17, 2013
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34Douglas R Strother, Lucie Lafay-Cousin, James M Boyett, et al.Neuro-Oncology|December 17, 2013
Brain tumor cell line authentication, an efficient alternative to capillary electrophoresis by using a microfluidics-based systemQian An, Helen L Fillmore, Mikaella Vouri, et al.Neuro-Oncology|November 9, 2013
HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal gliomaJun-Xia Zhang, Lei Han, Zhao-Shi Bao, et al.Neuro-Oncology|November 29, 2013
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomasAndrew L Lin, Jingxia Liu, John Evans, et al.Neuro-Oncology|November 29, 2013
Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiformeMichele Vidone, Federica Alessandrini, Gianluca Marucci, et al.Neuro-Oncology|November 29, 2013
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastomaKaisorn L Chaichana, Ignacio Jusue-Torres, Rodrigo Navarro-Ramirez, et al.Pageof 317